Literature DB >> 4297388

Intervertebral discolysis with collagenase.

B J Sussman.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4297388      PMCID： PMC2611465     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  8 in total

1.  ENZYME DISSOLUTION OF THE NUCLEUS PULPOSUS IN HUMANS.

Authors:  L SMITH
Journal:  JAMA       Date:  1964-01-11       Impact factor: 56.272

2.  Clostridium histolyticum collagenase: its purification and properties.

Authors:  I MANDL; H ZIPPER; L T FERGUSON
Journal:  Arch Biochem Biophys       Date:  1958-04       Impact factor: 4.013

3.  Evaluation of structural and chemical changes in connective tissue.

Authors:  J GROSS
Journal:  Ann N Y Acad Sci       Date:  1953-07-17       Impact factor: 5.691

4.  Whole mounts for the study of skin and its appendages.

Authors:  G W HAMBRICK; H BLANK
Journal:  J Invest Dermatol       Date:  1954-12       Impact factor: 8.551

5.  Treatment of lumbar intervertebral disc lesions by direct injection of chymopapain.

Authors:  L Smith; J E Brown
Journal:  J Bone Joint Surg Br       Date:  1967-08

6.  Effects of chymopapain in the intervertebral disc of the dog.

Authors:  W L Widdowson
Journal:  J Am Vet Med Assoc       Date:  1967-03-15       Impact factor: 1.936

7.  Tissue reactions to chymopapain in cats.

Authors:  C N Shealy
Journal:  J Neurosurg       Date:  1967-03       Impact factor: 5.115

8.  Reversible collapse of rabbit ears after intravenous papain, and prevention of recovery by cortisone.

Authors:  L THOMAS
Journal:  J Exp Med       Date:  1956-08-01       Impact factor: 14.307
  8 in total
  3 in total

1.  Intradiscal collagenase for treatment of lumbar disc herniations. A comparison of clinical results and computed tomography follow-up.

Authors:  E Wintermantel; H Emde; F Loew
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

2.  The collagenase of the bacterium Clostridium histolyticum does not favor metastasis of breast cancer.

Authors:  Yannick Fabian Diehm; Katharina Marstaller; Anna-Maria Seckler; Martin Reinhold Berger; Michael Zepp; Matthias Martin Gaida; Julia Thomé; Dimitra Kotsougiani-Fischer; Ulrich Kneser; Sebastian Fischer
Journal:  Breast Cancer       Date:  2022-02-07       Impact factor: 4.239

3.  The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease.

Authors:  Alexis Thomas; Ardeshir Bayat
Journal:  Ther Clin Risk Manag       Date:  2010-11-04       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.